41
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
May 31, 2026
6864962
656531
1
Public Timelines
FAQ

jan 1, 2014 - Pembrolizumab

Description:

FDA approves pembrolizumab for the treatment of advanced melanoma. This monoclonal antibody blocks the activity of a protein called PD1 on immune cells, which increases the strength of immune responses against cancer.

Added to timeline:

Date:

jan 1, 2014
Now
~ 12 years ago